NBC Securities Inc. lifted its position in CME Group Inc. (NASDAQ:CME - Free Report) by 72.6% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,979 shares of the financial services provider's stock after buying an additional 1,253 shares during the period. NBC Securities Inc.'s holdings in CME Group were worth $821,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of CME. Wayfinding Financial LLC purchased a new position in CME Group in the first quarter valued at about $25,000. Cornerstone Planning Group LLC lifted its position in shares of CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after purchasing an additional 55 shares during the last quarter. Golden State Wealth Management LLC raised its holdings in CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 98 shares in the last quarter. Ransom Advisory Ltd acquired a new position in CME Group in the 1st quarter valued at approximately $31,000. Finally, Alpine Bank Wealth Management bought a new stake in shares of CME Group in the 1st quarter valued at approximately $32,000. Hedge funds and other institutional investors own 87.75% of the company's stock.
CME Group Trading Up 0.4%
CME traded up $0.94 during mid-day trading on Friday, reaching $261.53. The stock had a trading volume of 3,139,055 shares, compared to its average volume of 2,291,844. The stock has a market capitalization of $94.25 billion, a P/E ratio of 25.32, a P/E/G ratio of 4.75 and a beta of 0.43. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The firm's fifty day simple moving average is $272.25 and its two-hundred day simple moving average is $270.52. CME Group Inc. has a 52 week low of $212.38 and a 52 week high of $290.79.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business's quarterly revenue was up 10.4% compared to the same quarter last year. During the same period last year, the company earned $2.56 EPS. On average, equities analysts predict that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be paid a $1.25 dividend. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group's dividend payout ratio is 48.40%.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on CME. Oppenheimer upped their price objective on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. Piper Sandler upped their price objective on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Citigroup increased their price target on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday, July 3rd. Finally, Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Four analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat, CME Group currently has an average rating of "Hold" and a consensus price target of $260.60.
Get Our Latest Stock Analysis on CME Group
Insider Buying and Selling
In other news, insider Timothy Francis Mccourt sold 379 shares of the stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider owned 9,508 shares of the company's stock, valued at $2,470,463.64. This represents a 3.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director William R. Shepard purchased 256 shares of the business's stock in a transaction dated Wednesday, June 25th. The stock was bought at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the purchase, the director owned 258,196 shares in the company, valued at $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders sold 13,043 shares of company stock worth $3,527,956. Company insiders own 0.30% of the company's stock.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.